BDNF and COVID-19: For instance, BDNF levels predict the need for intensive care in elderly with COVID-19, suggesting that lower BDNF levels may serve as a biomarker for more severe disease progression and poorer clinical outcomes in an age- and sex-specific manner [57, 58], especially when infection leads to severe pro-inflammatory cytokine responses.